These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12224001)
1. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma. Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001 [TBL] [Abstract][Full Text] [Related]
2. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Schuster V; Kreth HW Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803 [TBL] [Abstract][Full Text] [Related]
3. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483 [TBL] [Abstract][Full Text] [Related]
4. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992 [TBL] [Abstract][Full Text] [Related]
5. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines. Kis LL; Nagy N; Klein G; Klein E Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288 [TBL] [Abstract][Full Text] [Related]
7. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526 [TBL] [Abstract][Full Text] [Related]
8. X-linked lymphoproliferative disease: a progressive immunodeficiency. Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050 [TBL] [Abstract][Full Text] [Related]
9. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia]. Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391 [No Abstract] [Full Text] [Related]
10. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives]. Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052 [TBL] [Abstract][Full Text] [Related]
11. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819 [TBL] [Abstract][Full Text] [Related]
13. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S Front Pediatr; 2019; 7():183. PubMed ID: 31231620 [TBL] [Abstract][Full Text] [Related]
14. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease. Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488 [TBL] [Abstract][Full Text] [Related]
16. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma. Koochakzadeh L; Hosseinverdi S; Hedayat M; Farahani F; Tofighi A; Eghbali M; Bidoki AZ; Izadyar M; Rahiminejad MS; Ramyar A; Aghamohammadi A; Rezaei N Allergol Immunopathol (Madr); 2015; 43(6):568-70. PubMed ID: 25982576 [TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547 [TBL] [Abstract][Full Text] [Related]
18. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. Nagy N; Klein E Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]